CClinicalTrials.gg
Sign In
Status unknownNCT00840710BTUpdated Dec 29, 2009

Clinical Feasibility of Birth- Track II System

An observational study in Obstetrics and Labor, sponsored by Barnev Ltd. Status unknown at 1 site in Israel. Open to female participants aged 17 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-12-29.

Sponsored by Barnev Ltd · Observational

The sponsor has not verified this record recently (last verified Feb 2009), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
15
Ages
17 Years to 50 Years
Sex
Female
01

Study summary

The Study purpose is to monitor the cervix dilation, head descent, FHR and to follow contraction in a women in active labor.

02

Conditions studied

  • Obstetrics
  • Labor

Keywords

  • women in active labor
03

In context

Lead sponsor

Barnev Ltd is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women in active labor

Inclusion criteria

  1. Laboring women referred to the Maternity Center in active labor (3cm dilatation and contractions).
  2. Gestational age 37-42 weeks. (GA)
  3. Single fetus
  4. Subjects who understood, agreed and signed the informed consent form

Exclusion criteria

Exclusion Criteria:

  1. Women with abnormal placentation (placenta previa)
  2. Abnormal fetal presentation (breech presentation)
  3. Maternal History of HIV and/or blood transmitted hepatitis and/or active genital Herpes.
  4. Need for immediate delivery (cord prolapsed or suspected placental abruption)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
15 participants (estimated)
06

Study locations

1 site
  • Westren Gallilie Hospital
    Nahariya, Israel
    • Jacob Bornstein, Phd · Principal investigator
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00840710
Lead sponsor
Barnev Ltd
First posted
Feb 10, 2009
Start date
Feb 2010
Completion
Aug 2010 (estimated)
Last update
Dec 29, 2009

Study contacts

Jacob Bornestein, Phd.
Contact
049107207
Jacob Bornstein, PhD
principal investigator · Westren Gallilie Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Barnev Ltd

Start the discussion